Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Bracer 1mg tablets

Ferron Par Pharmaceuticals

Ingredients in every tablet

Anastrozole 1 mg

Each package contains

3 blisters of 10 tablets

Dosage form

tablet

Dosage formTablet; coated

Flavour

None

W.H.O. classification

L02B
L02B

A.T.C. Level 1

Anatomical Main group

L - Antineoplastic and immunomodulating agents
L02B

A.T.C. Level 2

Therapeutic subgroup

L02 - Endocrine Therapy Antineoplastic and Immunomodulating Agents
L02B

A.T.C. Level 3

Pharmacological subgroup

L02B - Hormone Antagonists and Related Agents

Available in

Indonesia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Pregnancy

NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Indication

Treatment of advanced breast cancer
Anastrozole is indicated for the treatment of advanced breast cancer in postmenopausal women with estrogen receptor positive and/or progesterone receptor positive.

Dosage

18 YEARS OLD AND ABOVE
1 tablet (1 mg) to be taken orally once a day.

Patients with advanced breast cancer:
Anastrozole should be continued until tumor progression is evident.

0 TO 18 YEARS OLD
Not recommended

PATIENTS WITH RENAL IMPAIRMENT
No dose change is recommended in patients with mild or moderate renal impairment.

PATIENTS WITH HEPATIC IMPAIRMENT
No dose change is recommended in patients with mild hepatic disease.